Latest News

Imaging studies may predict tumor response to anti-angiogenic drugs

Advanced imaging techniques may distinguish which patients' tumors will respond to treatment with anti-angiogenic drugs and which will not. In patients newly diagnosed with the dangerous brain tumor glioblastoma, those for whom treatment with the anti-angiogenic drug cediranib rapidly 'normalized' abnormal blood vessels around their tumors and increased blood flow within tumors survived significantly longer than did patients in whom cediranib did not increase blood flow.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • No direct link found between rising inequality, reduced trust

  • Diversity in developmental trajectories in kids with autism spectrum disorder

  • Common elements of STEM schools identified

  • Financial incentives help pregnant women to quit smoking

  • Grant to develop therapy to protect against nerve agents

  • Up to 2 per cent of Germany's population is dependent on hypnotics

  • Low-frequency deep brain stimulation improves difficult-to-treat Parkinson's symptoms

  • Sexual offending treatment programs in prisons, hospitals are ineffective

  • Fluorescent dyes 'light up' brain cancer cells

  • Stress shared by same-sex couples can have unique health impacts

  •